Becton, Dickinson and (BDX) Net Profit Margin: History & Chart

Becton, Dickinson and Company (BDX)BDXBecton, Dickinson and Company

About Becton, Dickinson and Company

Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, advanced laboratory equipment, and critical diagnostic products. Its extensive customer base comprises healthcare providers, clinical institutions, medical researchers, pharmaceutical firms, and the general public around the world. The BD Medical division delivers a comprehensive suite of products primarily focused on medication management and drug delivery. This encompasses a variety of intravenous (IV) access solutions, such as peripheral and advanced catheters, central lines, acute dialysis catheters, and related vascular care items including needle-free connectors and closed-system drug transfer devices. It also provides essential injection equipment like hypodermic syringes, needles, anesthesia trays, enteral syringes, and sharps disposal systems. Additionally, this segment develops integrated systems for IV medication and infusion therapy, medication compounding workflow, automated dispensing, and supply chain optimization. Specialized products for diabetes management, including pen needles, along with prefillable drug delivery systems, are also key offerings. BD Life Sciences focuses on diagnostic and research tools, offering products for specimen and blood collection. This segment supplies automated systems for culturing blood and tuberculosis, molecular testing, microorganism identification, and drug susceptibility analysis. It also provides liquid-based cytology systems, rapid diagnostic assays, microbiology laboratory automation, and plated media. Furthermore, it offers advanced solutions for cell analysis, including fluorescence-activated cell sorters and analyzers, antibodies, kits, and reagent systems. These are crucial for single-cell gene expression analysis, as well as for clinical oncology, immunological, and transplantation diagnostics and monitoring. Finally, the BD Interventional segment delivers specialized products for surgical and interventional procedures. Its portfolio includes solutions for hernia and soft tissue repair, biological and bioresorbable grafts, and biosurgery, alongside other surgical products. This segment also addresses surgical infection prevention, provides a range of surgical and laparoscopic instrumentation, offers peripheral intervention products, and supplies urology and critical care devices. Established in 1897, the company maintains its headquarters in Franklin Lakes, New Jersey.

Franklin Lakes, NJ

72,000 employees

www.bd.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Thomas E. Polen Jr.

View full financials

BDX Net Profit Margin Metrics

NET PROFIT MARGIN

-6.60%

NET PROFIT MARGIN AVG TTM

5.06%

NET PROFIT MARGIN AVG 3Y

7.63%

NET PROFIT MARGIN AVG 5Y

8.15%

NET PROFIT MARGIN AVG 10Y

7.46%

NET PROFIT MARGIN AVG 15Y

9.05%

NET PROFIT MARGIN AVG 20Y

10.74%

CURRENT VS TTM AVG

-230.34%

CURRENT VS 3Y AVG

-186.52%

CURRENT VS 5Y AVG

-180.96%

CURRENT VS 10Y AVG

-188.46%

CURRENT VS 15Y AVG

-172.91%

CURRENT VS 20Y AVG

-161.44%

SECTOR MEDIAN · HEALTHCARE

10.44%

median of 79 covered companies

CURRENT VS SECTOR MEDIAN

-163.19%

vs the sector median at left

NAME	MARKET CAP	NET PROFIT MARGIN	TTM	3Y	5Y
Becton, Dickinson and Company (BDX)	$60.26B	-6.60%	5.06%	7.63%	8.15%
Cencora, Inc. (COR)vs ›	$62.18B	0.78%	0.49%	0.59%	0.22%
Cardinal Health, Inc. (CAH)vs ›	$54.46B	0.62%	0.54%	0.18%	-0.22%
Boston Scientific Corporation (BSX)vs ›	$68.46B	17.24%	12.73%	10.54%	8.34%
Regeneron Pharmaceuticals, Inc. (REGN)vs ›	$71.62B	29.65%	31.24%	32.06%	36.64%
Edwards Lifesciences Corporation (EW)vs ›	$48.18B	17.34%	47.22%	37.68%	33.03%
Humana Inc. (HUM)vs ›	$46.67B	0.82%	0.97%	1.82%	2.53%
IDEXX Laboratories, Inc. (IDXX)vs ›	$44.93B	24.63%	23.70%	22.66%	22.55%
Cigna Corporation (CI)vs ›	$79.64B	2.26%	1.78%	2.48%	3.04%
IQVIA Holdings Inc. (IQV)vs ›	$40.61B	8.10%	8.63%	8.47%	7.22%

NAME

MARKET CAP

NET PROFIT MARGIN

TTM

Becton, Dickinson and Company (BDX)

$60.26B

-6.60%

5.06%

7.63%

8.15%

Cencora, Inc. (COR)vs ›

$62.18B

0.78%

0.49%

0.59%

0.22%

Cardinal Health, Inc. (CAH)vs ›

$54.46B

0.62%

0.54%

0.18%

-0.22%

Boston Scientific Corporation (BSX)vs ›

$68.46B

17.24%

12.73%

10.54%

8.34%

Regeneron Pharmaceuticals, Inc. (REGN)vs ›

$71.62B

29.65%

31.24%

32.06%

36.64%

Edwards Lifesciences Corporation (EW)vs ›

$48.18B

17.34%

47.22%

37.68%

33.03%

Humana Inc. (HUM)vs ›

$46.67B

0.82%

0.97%

1.82%

2.53%

IDEXX Laboratories, Inc. (IDXX)vs ›

$44.93B

24.63%

23.70%

22.66%

22.55%

Cigna Corporation (CI)vs ›

$79.64B

2.26%

1.78%

2.48%

3.04%

IQVIA Holdings Inc. (IQV)vs ›

$40.61B

8.10%

8.63%

8.47%

7.22%

Net Profit Margin FAQ

What is the net profit margin for Becton, Dickinson and Company (BDX)?

The net profit margin for BDX stock is -6.60%.

Is Becton, Dickinson and Company's net profit margin high or low?

The net profit margin of -6.60% is 189% below its 5-year average of 7.45%, near the low end of its 5-year range (-6.60%–14.35%).

What is the TTM average net profit margin for Becton, Dickinson and Company (BDX)?

The TTM average net profit margin for BDX stock is 5.06%.

What is the 3Y average net profit margin for Becton, Dickinson and Company (BDX)?

The 3Y average net profit margin for BDX stock is 7.63%.

What is the 5Y average net profit margin for Becton, Dickinson and Company (BDX)?

The 5Y average net profit margin for BDX stock is 8.15%.

What is the 10Y average net profit margin for Becton, Dickinson and Company (BDX)?

The 10Y average net profit margin for BDX stock is 7.46%.

What is the 15Y average net profit margin for Becton, Dickinson and Company (BDX)?

The 15Y average net profit margin for BDX stock is 9.05%.

What is the 20Y average net profit margin for Becton, Dickinson and Company (BDX)?

The 20Y average net profit margin for BDX stock is 10.74%.

DATE	NET PROFIT MARGIN
2026-03-31	-6.60%
2025-12-31	7.27%
2025-09-30	8.37%
2025-06-30	10.42%
2025-03-31	5.84%
2024-12-31	5.86%
2024-09-30	7.36%
2024-06-30	9.76%
2024-03-31	10.64%
2023-12-31	5.97%
2023-09-30	2.12%
2023-06-30	8.34%
2023-03-31	9.54%
2022-12-31	11.10%
2022-09-30	6.05%
2022-06-30	7.76%
2022-03-31	9.56%
2021-12-31	14.35%
2021-09-30	5.16%
2021-06-30	11.40%
2021-03-31	6.09%
2020-12-31	18.87%
2020-09-30	2.68%
2020-06-30	7.42%
2020-03-31	4.30%
2019-12-31	6.58%
2019-09-30	3.53%
2019-06-30	10.37%
2019-03-31	0.48%
2018-12-31	14.40%
2018-09-30	-3.07%
2018-06-30	13.88%
2018-03-31	-0.28%
2017-12-31	-4.42%
2017-09-30	10.33%
2017-06-30	-4.35%
2017-03-31	11.59%
2016-12-31	19.23%
2016-09-30	0.59%
2016-06-30	12.20%
2016-03-31	11.02%
2015-12-31	7.67%
2015-09-30	5.92%
2015-06-30	1.99%
2015-03-31	10.53%
2014-12-31	11.51%
2014-09-30	13.67%
2014-06-30	15.11%
2014-03-31	13.85%
2013-12-31	13.45%
2013-09-30	4.30%
2013-06-30	14.71%
2013-03-31	13.80%
2012-12-31	32.89%
2012-09-30	14.69%
2012-06-30	16.50%
2012-03-31	15.09%
2011-12-31	14.36%
2011-09-30	14.63%
2011-06-30	17.58%
2011-03-31	16.23%
2010-12-31	17.15%
2010-09-30	22.90%
2010-06-30	16.76%
2010-03-31	16.54%
2009-12-31	16.93%
2009-09-30	16.72%
2009-06-30	18.74%
2009-03-31	15.15%
2008-12-31	18.17%
2008-09-30	15.37%
2008-06-30	15.91%
2008-03-31	15.81%
2007-12-31	15.92%
2007-09-30	15.74%
2007-06-30	15.01%
2007-03-31	15.39%
2006-12-31	9.52%
2006-09-30	11.69%
2006-06-30	14.16%
2006-03-31	10.82%
2005-12-31	15.63%
2005-09-30	10.81%
2005-06-30	13.73%
2005-03-31	13.78%
2004-12-31	15.16%
2004-09-30	5.59%
2004-06-30	8.80%
2004-03-31	13.17%
2003-12-31	10.58%
2003-09-30	13.71%
2003-06-30	11.16%
2003-03-31	12.53%
2002-12-31	10.81%
2002-09-30	12.20%
2002-06-30	11.99%

DATE

NET PROFIT MARGIN

2026-03-31

-6.60%

2025-12-31

7.27%

2025-09-30

8.37%

2025-06-30

10.42%

2025-03-31

5.84%

2024-12-31

5.86%

2024-09-30

7.36%

2024-06-30

9.76%

2024-03-31

10.64%

2023-12-31

5.97%

2023-09-30

2.12%

2023-06-30

8.34%

2023-03-31

9.54%

2022-12-31

11.10%

2022-09-30

6.05%

2022-06-30

7.76%

2022-03-31

9.56%

2021-12-31

14.35%

2021-09-30

5.16%

2021-06-30

11.40%

2021-03-31

6.09%

2020-12-31

18.87%

2020-09-30

2.68%

2020-06-30

7.42%

2020-03-31

4.30%

2019-12-31

6.58%

2019-09-30

3.53%

2019-06-30

10.37%

2019-03-31

0.48%

2018-12-31

14.40%

2018-09-30

-3.07%

2018-06-30

13.88%

2018-03-31

-0.28%

2017-12-31

-4.42%

2017-09-30

10.33%

2017-06-30

-4.35%

2017-03-31

11.59%

2016-12-31

19.23%

2016-09-30

0.59%

2016-06-30

12.20%

2016-03-31

11.02%

2015-12-31

7.67%

2015-09-30

5.92%

2015-06-30

1.99%

2015-03-31

10.53%

2014-12-31

11.51%

2014-09-30

13.67%

2014-06-30

15.11%

2014-03-31

13.85%

2013-12-31

13.45%

2013-09-30

4.30%

2013-06-30

14.71%

2013-03-31

13.80%

2012-12-31

32.89%

2012-09-30

14.69%

2012-06-30

16.50%

2012-03-31

15.09%

2011-12-31

14.36%

2011-09-30

14.63%

2011-06-30

17.58%

2011-03-31

16.23%

2010-12-31

17.15%

2010-09-30

22.90%

2010-06-30

16.76%

2010-03-31

16.54%

2009-12-31

16.93%

2009-09-30

16.72%

2009-06-30

18.74%

2009-03-31

15.15%

2008-12-31

18.17%

2008-09-30

15.37%

2008-06-30

15.91%

2008-03-31

15.81%

2007-12-31

15.92%

2007-09-30

15.74%

2007-06-30

15.01%

2007-03-31

15.39%

2006-12-31

9.52%

2006-09-30

11.69%

2006-06-30

14.16%

2006-03-31

10.82%

2005-12-31

15.63%

2005-09-30

10.81%

2005-06-30

13.73%

2005-03-31

13.78%

2004-12-31

15.16%

2004-09-30

5.59%

2004-06-30

8.80%

2004-03-31

13.17%

2003-12-31

10.58%

2003-09-30

13.71%

2003-06-30

11.16%

2003-03-31

12.53%

2002-12-31

10.81%

2002-09-30

12.20%

2002-06-30

11.99%

Net Profit Margin: -6.60%

BDX Profit Margin

BDX Average Net Profit Margin Chart

BDX Current vs Average Net Profit Margin Chart

BDX Net Profit Margin Metrics

BDX Competitors' Net Profit Margin

Margin Comparison

Net Profit Margin Formula & Definition

Net Profit Margin FAQ

BDX Net Profit Margin History

Related Metrics